Medscape

Off-Label Drug Use Linked to More Adverse Events

The off-label use of prescription drugs is associated with more adverse drug events (ADEs) in adults than on-label use, especially when off-label indications are not backed by solid data, according to ...
ascopubs.org

Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists

Prescribing data from IntrinsiQ Intellidose data systems, a pharmacy software provider maintaining a population-based cohort database of medical oncologists, was analyzed. Use of the most commonly ...
clinicaladvisor.com

Little Evidence of Gabapentin Efficacy for Off-Label Uses

off label button Clinicians who prescribe gabapentin for off-label uses should assess available evidence for a given indication. Clinicians who prescribe gabapentin for off-label uses should assess ...
ascopubs.org

Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny Labeling

Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study Generic competition can be delayed if ...
Medscape

Unlabeled Uses of Intravenous Immune Globulin

Purpose: The unlabeled uses of intravenous immune globulin (IVIG) were reviewed. Summary: A literature review was conducted to identify studies examining the unlabeled uses of IVIG. A review of 138 ...
Business Wire

FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration (FDA) ...